Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 49.20% is in line with its 5-year average of 47.99%, around the middle of its 5-year range (40.85%–57.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.00% below its 12-month average of 52.34%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
49.20%
DEBT TO ASSETS RATIO AVG TTM
52.34%
DEBT TO ASSETS RATIO AVG 3Y
51.61%
DEBT TO ASSETS RATIO AVG 5Y
47.99%
DEBT TO ASSETS RATIO AVG 10Y
38.90%
DEBT TO ASSETS RATIO AVG 15Y
32.90%
DEBT TO ASSETS RATIO AVG 20Y
30.62%
CURRENT VS TTM AVG
-6.00%
CURRENT VS 3Y AVG
-4.65%
CURRENT VS 5Y AVG
+2.52%
CURRENT VS 10Y AVG
+26.49%
CURRENT VS 15Y AVG
+49.57%
CURRENT VS 20Y AVG
+60.69%
SECTOR MEDIAN · HEALTHCARE
0.28%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+17473.09%
vs the sector median at left
Bristol-Myers Squibb Company
Market Cap
$136.49B
Debt to Assets Ratio
49.20%
TTM Avg
52.34%
3Y Avg
51.61%
5Y Avg
47.99%
Market Cap
$138.61B
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$129.55B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.31B
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Company (BMY) | $136.49B | 49.20% | 52.34% | 51.61% | 47.99% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $138.61B | 0.07% | N/A | N/A | N/A |
| Intuitive Surgical, Inc. (ISRG)vs › | $129.55B | 0.00% | N/A | N/A | N/A |
| Danaher Corporation (DHR)vs › | $145.98B | 0.29% | N/A | N/A | N/A |
| CVS Health Corp. (CVS)vs › | $123.43B | 0.30% | N/A | N/A | N/A |
| Medtronic plc (MDT)vs › | $120.54B | 0.00% | N/A | N/A | N/A |
| Stryker Corporation (SYK)vs › | $116.21B | 0.31% | N/A | N/A | N/A |
| Pfizer Inc. (PFE)vs › | $162.15B | 0.31% | N/A | N/A | N/A |
| McKesson Corporation (MCK)vs › | $106.31B | 0.13% | N/A | N/A | N/A |
| Sanofi (SNY)vs › | $106.23B | 0.18% | N/A | N/A | N/A |
Debt/Assets
49.2%
Debt/Equity
1.93
Current Ratio
1.53
Interest Coverage
7.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 49.20% |
| 2026-03-31 | 53.69% |
| 2025-12-31 | 52.35% |
| 2025-09-30 | 52.68% |
| 2025-06-30 | 53.79% |
| 2025-03-31 | 55.44% |
| 2024-12-31 | 55.29% |
| 2024-09-30 | 54.87% |
| 2024-06-30 | 57.06% |
| 2024-03-31 | 57.97% |
| 2023-12-31 | 43.57% |
| 2023-09-30 | 43.03% |
| 2023-06-30 | 41.92% |
| 2023-03-31 | 41.76% |
| 2022-12-31 | 42.05% |
| 2022-09-30 | 40.85% |
| 2022-06-30 | 42.89% |
| 2022-03-31 | 44.64% |
| 2021-12-31 | 41.71% |
| 2021-09-30 | 41.34% |
| 2021-06-30 | 41.78% |
| 2021-03-31 | 42.04% |
| 2020-12-31 | 43.61% |
| 2020-09-30 | 36.49% |
| 2020-06-30 | 37.10% |
| 2020-03-31 | 36.76% |
| 2019-12-31 | 36.58% |
| 2019-09-30 | 43.57% |
| 2019-06-30 | 45.40% |
| 2019-03-31 | 17.39% |
| 2018-12-31 | 21.01% |
| 2018-09-30 | 21.66% |
| 2018-06-30 | 22.63% |
| 2018-03-31 | 23.27% |
| 2017-12-31 | 23.73% |
| 2017-09-30 | 24.85% |
| 2017-06-30 | 24.60% |
| 2017-03-31 | 25.61% |
| 2016-12-31 | 19.90% |
| 2016-09-30 | 20.24% |
| 2016-06-30 | 20.52% |
| 2016-03-31 | 21.01% |
| 2015-12-31 | 21.07% |
| 2015-09-30 | 22.89% |
| 2015-06-30 | 23.06% |
| 2015-03-31 | 22.21% |
| 2014-12-31 | 23.21% |
| 2014-09-30 | 22.92% |
| 2014-06-30 | 23.09% |
| 2014-03-31 | 22.88% |
| 2013-12-31 | 21.61% |
| 2013-09-30 | 19.60% |
| 2013-06-30 | 19.88% |
| 2013-03-31 | 21.95% |
| 2012-12-31 | 20.60% |
| 2012-09-30 | 20.42% |
| 2012-06-30 | 17.19% |
| 2012-03-31 | 16.71% |
| 2011-12-31 | 16.65% |
| 2011-09-30 | 17.55% |
| 2011-06-30 | 17.34% |
| 2011-03-31 | 17.54% |
| 2010-12-31 | 17.52% |
| 2010-09-30 | 21.08% |
| 2010-06-30 | 21.06% |
| 2010-03-31 | 20.45% |
| 2009-12-31 | 20.51% |
| 2009-09-30 | 21.30% |
| 2009-06-30 | 21.33% |
| 2009-03-31 | 22.39% |
| 2008-12-31 | 22.85% |
| 2008-09-30 | 21.97% |
| 2008-06-30 | 27.86% |
| 2008-03-31 | 24.47% |
| 2007-12-31 | 23.96% |
| 2007-09-30 | 23.48% |
| 2007-06-30 | 26.62% |
| 2007-03-31 | 28.26% |
| 2006-12-31 | 29.07% |
| 2006-09-30 | 31.11% |
| 2006-06-30 | 30.76% |
| 2006-03-31 | 31.00% |
| 2005-12-31 | 30.55% |
| 2005-09-30 | 24.10% |
| 2005-06-30 | 24.97% |
| 2005-03-31 | 30.17% |
| 2004-12-31 | 33.99% |
| 2004-09-30 | 33.77% |
| 2004-06-30 | 32.38% |
| 2004-03-31 | 33.18% |
| 2003-12-31 | 31.89% |
| 2003-09-30 | 32.83% |
| 2003-06-30 | 32.12% |
| 2003-03-31 | 33.97% |
| 2002-12-31 | 30.53% |
| 2002-09-30 | 28.05% |
